Skip to main content
All lobbying filings

CONTINENTAL STRATEGY, LLC

Lobbying for IMMUNITYBIO, INC. · Immunotherapy company focused on developing treatments for cancer and infectious diseases.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · California · $60,000.00 income · posted Jan 19, 2026

Official filing document

 Lobbying activity 1
Health Issues

Federal support for medical research, development and manufacturing, approval and distribution.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem